¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Fat, trans"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® fat ÇÑ±Û Áö¹æ
¼³¸í   
  1. Áö¹æÁ¶Á÷À» ³ªÅ¸³»´Â ¸». Áï Èò»öÀ̳ª ³ë¶õ»öÀ» ¶ì´Â ¿¡³ÊÁö¸¦ º¸°üÇϴ ±â´ÉÀ» Çϴ Á¶Á÷. ¿©·¯ °¡Áö ±â°üµé »çÀÌ¿¡ Á¸ÀçÇÑ´Ù. 2. Áö¹æ»ê°ú ±Û¸®¼¼·ÑÀÌ °áÇÕÇÑ À¯±â È­ÇÕ¹°. »ó¿Â¿¡¼­ °íüÀÇ ÇüÅÂÀ̸ç, »ý¹°Ã¼¿¡ ÇÔÀ¯µÇ¾î ÀÖ´Ù. µ¿¹°¿¡¼­´Â ÇÇÇÏ-±ÙÀ°-°£ µûÀ§¿¡ ÀúÀåµÇ¸ç, ¿¡³ÊÁö¿øÀÌÁö¸¸ ¸ö¹«°Ô°¡ ´À´Â ¿øÀÎÀÌ µÇ±âµµ ÇÑ´Ù. ±Û¸®¼¼·ÑÀÌ 3°¡ÀÇ ¾ËÄÚ¿ÃÀ̹ǷΠÁö¹æ»êÀº ¼Â±îÁö °áÇÕÇÒ ¼ö Àִµ¥, Áö¹æ»êÀÌ Çϳª °áÇÕÇÑ °ÍÀ» ¸ð³ë¾Æ½Ç±Û¸®¼¼·Ñ(monoacylglycerol) µÑÀÌ °áÇÕÇÑ °ÍÀ» µð¾Æ½Ç±Û¸®¼¼·Ñ(diacylglycerol) ¼ÂÀÌ °áÇÕÇÑ °ÍÀ» Æ®¸®¾Æ½Ç±Û¸®¼¼·Ñ(triacylglycerol) À̶ó°í ÇÑ´Ù. »ýü³»ÀÇ ¸ð³ë¾Æ½Ç±Û¸®¼¼·Ñ ¹× µð¾Æ½Ç±Û¸®¼¼·ÑÀº ±ØÈ÷ ÀûÀº ¾çÀÌÁö¸¸, ÁöÁú´ë»ç¿¡ Áß¿äÇÑ ÀÛ¿ëÀ» ÇÑ´Ù. Æ®¸®¾Æ½Ç±Û¸®¼¼·ÑÀº ±Û¸®ÄÚ°Õ°ú ÇÔ²² ÀúÀå¿¡³ÊÁö·Î µÇ¾î ÀÖ´Ù.
¿µ¹® saturated fat ÇÑ±Û Æ÷È­Áö¹æ
¼³¸í   
  Åº¼Ò °áÇÕÀÌ ¸ðµÎ ´ÜÀÏ °áÇÕÀ¸·Î ±¸¼ºµÈ Áö¹æ»êÀ¸·Î ÀÌ·ç¾îÁø Áö¹æÀ» ¸»ÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • body fat
    üÁö¹æ, ¸öÁö¹æ
  • brown fat
    °¥»öÁö¹æ
  • buccal fat pad
    º¼Áö¹æµ¢ÀÌ, º¼Áö¹æÃ¼
  • fat
    Áö¹æ
  • fat atrophy
    Áö¹æÀ§Ãà
  • fat blood level
    Áö¹æÇ÷Ãþ
  • fat cell
    Áö¹æ¼¼Æ÷
  • fat deficiency disease
    Áö¹æ°áÇ̺´
  • fat depot
    ÀúÀåÁö¹æ
  • fat embolism
    Áö¹æ»öÀüÁõ
  • fat metabolism
    Áö¹æ´ë»ç
  • fat necrosis
    Áö¹æ±«»ç
  • fat pad sign
    Áö¹æÆÐµå¡ÈÄ
  • fat-free body mass
    Áö¹æÁ¦¿ÜüÁß
  • fat-soluble
    Áö¿ë¼º-
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • trans
    °æ-, °æÀ¯-, Åë°ú-
  • fat embolism
    Áö¹æ»öÀüÁõ
  • fat
    Áö¹æ
  • body fat
    ¸öÁö¹æ, üÁö¹æ
  • milk fat
    ¿ìÀ¯Áö¹æ, À¯Áö¹æ
  • subcutaneous fat
    ÇǺιØÁö¹æ, ÇÇÇÏÁö¹æ
  • traumatic fat necrosis
    ¿Ü»óÁö¹æ±«»ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • trans
    °æ-, °æÀ¯-, Åë°ú-
  • fat atrophy
    Áö¹æÀ§Ãà
  • body fat
    ¸öÁö¹æ, üÁö¹æ
  • buccal fat pad
    º¼Áö¹æµ¢ÀÌ
  • buccal fat pad excision
    º¼Áö¹æÃ¼ÀýÁ¦¼ú
  • fat cell
    Áö¹æ¼¼Æ÷
  • fat-storing cell
    Áö¹æÀúÀå¼¼Æ÷
  • depot fat
    ÀúÀåÁö¹æ
  • fat deficiency disease
    Áö¹æ°áÇÌÁõ
  • mutton fat deposit
    ±»±â¸§Ä§Âø¹°
  • elbow fat pad sign
    ÆÈ²ÞÄ¡Áö¹æÆÐµå¡ÈÄ
  • fat embolism
    Áö¹æ»öÀüÁõ
  • fat
    Áö¹æ
  • fat-soluble
    Áö¿ë¼º-
  • fascia-fat flap
    ±Ù¸·Áö¹æÇÇÆÇ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Fat
    Áö¹æ(ò·Û¸)
  • Fat cells
    Áö¹æ(ò·Û¸)¼¼Æ÷(á¬øà)
  • Fat-soluble vitamins
    Áö¿ë¼º(ò·éÁàõ)ºñŸ¹Î
  • frequency selective fat suppression technique
    Á֯ļö ¼±Åà Áö¹æ ¾ïÁ¦(±â)¹ý
  • half fat cheese
    ¹ÝÅ»ÁöÄ¡ÀÌÁî.
  • high fat diet
    °íÁö¹æ½ÄÀÌ.
  • hypodermic fat
    ÇÇÇÏÁö¹æ(¡­ò·Û¸).
  • infrapatellar fat pad
    ½½°³ÇÏ Áö¹æÃ¼(ã£ËÏù»ò· Û¸ô÷), ½½°³ÇÏ Áö¹æ ÆÐµå.
  • infrapatellar fat pad
    ¹«¸­¹ØÁö¹æ
  • phase evolution of fat suppression
    À§»ó ¼±È¸ Áö¹æ ¾ïÁ¦
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cis-trans test
    ½Ã½º-Æ®·£½º°Ë»ç
  • bone fat
    °ñÁö(Íéò·).
  • breast,traumatric fat necrosis
    ¿Ü»ó¼º Áö¹æ±«»ç (èâß¿àõò·Û¸ÎÕÞÝ)
  • brown fat
    ºê¶ó¿î Áö¹æ(ò·Û°)
  • brown fat
    °¥»öÁö¹æ(ü)(¡­ò·Û¸ô÷).
  • brown fat tissue
    °¥»öÁö¹æÁ¶Á÷(¡­ò·Û¸ðÚòÄ).
  • brown fat tissue
    °¥»öÁö¹æÁ¶Á÷
  • depot fat
    ÀúÀåÁö¹æ(îÍíúò·Û¸).
  • elbow fat pad sign
    ÆÈ²ÞÄ¡ Áö¹æ ÆÐµå¡ÈÄ(~ó£ý¦).
  • embolism,fat
    Áö¹æ(ò·Û¸)
  • fat
    Áö¹æ(ò·Û¸).
  • fat atrophy
    Áö¹æ À§Ãà
  • fat blood level
    Áö¹æÇ÷ Ãþ
  • fat cell
    Áö¹æ¼¼Æ÷(¡­á¬øà).
  • fat cell
    Áö¹æ¼¼Æ÷
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Brown fat tissue
    °¥»öÁö¹æÁ¶Á÷
    [¿¾ ¿ë¾î] °¥»öÁö¹æÁ¶Á÷
  • Fat-storing cell
    µ¿±¼ÁÖÀ§Áö¹æ¼¼Æ÷
    [¿¾ ¿ë¾î] µ¿¾çÇ÷°üÁÖÀ§Áö¹æ¼¼Æ÷
  • Infrapatellar fat pad
    ¹«¸­¹ØÁö¹æ
    [¿¾ ¿ë¾î] ½½°³ÇÏÁö¹æÃ¼
  • Multilocular fat cell
    ¹µÄ­Áö¹æ¼¼Æ÷
    [¿¾ ¿ë¾î] ´Ù¹æ¼ºÁö¹æ¼¼Æ÷
  • White fat tissue
    ¹é»öÁö¹æÁ¶Á÷
    [¿¾ ¿ë¾î] ¹é»öÁö¹æÁ¶Á÷
  • Fat droplet
    Áö¹æ¹æ¿ï
    [¿¾ ¿ë¾î] Áö¹æÀû
  • Pararenal fat pad
    ÄáÆÏÁÖÀ§Áö¹æÃ¼
    [¿¾ ¿ë¾î] ½ÅÀ广Áö¹æÃ¼
  • Unilocular fat cell
    ȬĭÁö¹æ¼¼Æ÷
    [¿¾ ¿ë¾î] ´Ü¹æ¼ºÁö¹æ¼¼Æ÷
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cis-trans isomers
    ½Ã½ºÆ®¶õ½º À̼ºÃ¼(ì¶àõô÷)
  • cis-trans test
    ½Ã½ºÆ®¶õ½º ½ÃÇè(ãËúÐ)
  • trans
    Æ®¶õ½º
  • trans-acting locus
    Æ®¶õ½ºÀÛ¿ëºÎÀ§ (íÂéÄÝ»êÈ)
  • trans effect
    Æ®¶õ½º È¿°ú(üùÍý)
  • TRANS-IF
    (å²) transient state isoelectric focusing
  • trans isomer
    Æ®¶õ½ºÀ̼ºÃ¼(ì¶àõô÷)
  • brown fat
    °¥»öÁö¹æ(Êèßäò·Û¸)
  • depot fat
    ÀúÀåÁö¹æ(îÍíúò·Û¸)
  • fat
    Áö¹æ(ò·Û¸)
  • fat body
    Áö¹æÃ¼(ò·Û¸ô÷)
  • fat-soluble A
    Áö¿ë¼º(ò·éÁàõ) A
  • fat solvent
    Áö¹æ ¿ë¸Å(ò·Û¸éÁØÚ)
  • fat-splitting
    Áö¹æ ºÐÇÒ(ò·Û¸ÝÂùÜ)
  • neutral fat
    Áß¼ºÁö¹æ(ñéàõò·Û¸)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fat
    Áö¹æ
  • fat blood level
    Áö¹æÇ÷Ãþ
  • fat cell
    Áö¹æ¼¼Æ÷
  • fat degeneration
    Áö¹æº¯¼º
  • fat embolism
    Áö¹æ»öÀüÁõ
  • fat globule
    Áö¹æ±¸
  • fat image
    Áö¹æ¿µ»ó
  • fat infiltration
    Áö¹æÄ§À±
  • fat meal
    Áö¹æ½Ä
  • fat pad sign
    Áö¹æÆÐµå¡ÈÄ
  • fat plane
    Áö¹æ¸é
  • fat saturation pulse
    Áö¹æÆ÷È­ÆÞ½º
  • fat suppression
    Áö¹æ¾ïÁ¦
  • frequency selective fat suppression technique
    Á֯ļö¼±Åà Áö¹æ¾ïÁ¦(±â)¹ý
  • phase evolution of fat suppression
    À§»ó¼±È¸ Áö¹æ¾ïÁ¦
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
BF bentonite flocculation; bile flow; black female; blastogenic factor; blister fluid; blood flow; body...
OTC Ornithine Trans-Carbamylase
PTHC Percutaneous Trans-Hepatic Cholangiography(-gram)
  = PTC
TAE Trans-Arterial(-Catheter) Embolization
  Angiography¿Í µ¿½Ã¿¡ Gel Form°ú CTx AgentÀÇ Mixed m...
TBLB Trans-Bronchial Lung Biopsy
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
% FAT fat
ALL-Trans RA ALL-Trans Retinoic acid
tt-MA Trans, trans-muconic acid
trans-ACPD Trans-1-amino-1,3-cyclopentanedicarboxylic acid
AF Abdominal fat
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • { ¥Ä}^{ 1}

    -3,4-trans[

    { ¥Ä}^{9 }

    -THC Ȥ
    ´ë¸¶ °ü·Ã Àå¾Ö, ´ë¸¶ °ü·Ã º´
  • cis-trans
    ½Ã½º-Æ®¶õ½º ½ÃÇè
    ¹Ì»ý¹° À¯ÀüÇп¡¼­, µ¿ÀÏÇÑ Ç¥ÇöÇü È¿°ú¸¦ °®´Â µÎ °¡Áö µ¹¿¬º¯À̰¡ µ¿ÀÏÇÑ À¯ÀüÀÚ³»¿¡ Á¸ÀçÇÏ´ÂÁö ¶Ç´Â ´Ù¸¥ À¯ÀüÀÚ¿¡ Á¸ÀçÇÏ´ÂÁö¸¦ ÆÇÁ¤ÇÏ´Â ½ÃÇè.
  • trans urethral resection
    °æ¿äµµÀû Àü±â ÀýÁ¦¼ú
    Àü¸³¼± ºñ´ëÁõÀ̳ª ¹æ±¤Áõ µîÀ» °³º¹ÇÏÁö ¾Ê°í ¿äµµ¸¦ ÅëÇØ¼­ ³»½Ã°æÀûÀ¸·Î ÀýÁ¦ÇÏ´Â ¼ö¼ú ¹æ¹ý. ¸ÕÀú ¹æ±¤ ¿äµµ¿ë ÆÄÀ̹ö½ºÄÚÇÁ¿¡ ¼ö¼ú¿ë ÀåÄ¡°¡ ´Þ¸° ³»°æ 8~9 mmÀÇ °¡´À´Ù¶õ ÀýÁ¦°æ
  • elbow fat pad sign
    ÆÈ²ÞÄ¡ Áö¹æ ÆÐµå ¡ÈÄ
  • fat
    Áö¹æ, Áö¹æ Á¶Á÷
    ¹é»öÀ̳ª ´ãȲ»öÀÇ Á¶Á÷À¸·Î ½ÅüÀÇ ¿©·¯ ±â°ü »çÀÌ¿¡¼­ ¿¬ÇÑ ÆÐµå¸¦ Çü¼ºÇÏ¿© ½ÅüÀÇ À±°ûÀ» ºÎµå·´°Ô Çϰųª ¿¡³ÊÁöÀÇ ÀúÀå ¿ªÇÒÀ» ÇÑ´Ù. ±Û¸®¼¼¸° Áö¹æ»ê ¿¡½ºÅÍ.
  • fat cell
    Áö¹æ ¼¼Æ÷
  • fat degeneration
    Áö¹æ º¯¼º
  • fat embolism syndrome
    Áö¹æ »öÀü ÁõÈıº
    Áö¹æ ¼ººÐÀÌ ´ëºÎºÐÀΠȲ»ö °ñ¼ö·Î µÈ °ñÀÇ °ñÀý ¶Ç´Â Áö¹æ Á¶Á÷ÀÇ ½ÉÇÑ ¿Ü»ó ÈÄ¿¡ Á¡ÁøÀû Æó ºÎÀüÁõ, Á¤½Å·Â ÀúÇÏ¿Í ½Å ºÎÀüÁõÀ» ÃÊ·¡ÇÏ´Â °ÍÀ» ¸»ÇÑ´Ù. ÀÌ´Â ÆÄ¿­µÈ Ç÷°ü ¼ÓÀ¸·Î ¹«¼öÇÑ Áö¹æ±¸°¡ µé¾î°¡ ¿©·¯ Àå±â¿¡ ºÐÆ÷ÇÑ Ç÷°ü¿¡ »öÀüÁõÀ» ¾ß±âÇÔÀ¸·Î½á ÀϾ´Ù. ÀϹÝÀûÀ¸·Î º´ÀηÐÀº º¹ÇÕÀûÀÌ´Ù. ÀÏ´Ü ÀÌ ÁõÈıºÀÌ ¹ß»ýÇÏ¸é ¸Å¿ì À§µ¶ÇÏ¿© ´ë·« 10-15%ÀÇ »ç¸Á·üÀ» ³ªÅ¸³½´Ù.
  • fat graft
    Áö¹æ ÀÌ½ÄÆí, Áö¹æ À̽Ä
    ÁöÁö Á¶Á÷¿¡¼­ ¿ÏÀüÈ÷ À¯¸®½ÃŲ Áö¹æÀÇ À̽Ä. ÇÔ¸ôºÎ¸¦ ¸Þ¿ì±â À§ÇØ »ç¿ëÇÑ´Ù.
  • fat infiltration
    Áö¹æ ħÀ±
  • fat necrosis
    Áö¹æ ±«»ç
  • fat plane
    Áö¹æ ¸é
  • fat soluble
    Áö¿ë¼ºÀÇ
  • fat suppression
    Áö¹æ ¾ïÁ¦
  • frequency selective fat suppression technique
    ÁÖÆÄ ¼ö ¼±Åà Áö¹æ ¾ïÁ¦ ±â¹ý, Á֯ļö ¼±Åà Áö¹æ ¾ïÁ¦ ±â¹ý
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
all-trans-retinal The orange retinaldehyde resulting from the action of light on the rhodopsin of the retina, which converts the 11-cis-retinal component of the rhodopsin to all-trans-retinal plus opsin.
Synonym: trans-retinal, visual yellow.
(05 Mar 2000)
peptidyl prolyl cis trans isomerase See: PPIase and immunophilin.
(18 Nov 1997)
cis-9,trans-11-octadecadienoate reductase <enzyme> Uses NADH and alpha-tocopherol quinol; forms trans-11-octadecenoate
Registry number: EC 1.3.1.-
Synonym: 9,11-ocdd reductase
(26 Jun 1999)
cis-trans-isomerases <enzyme> Enzymes that catalyze the rearrangement of geometry about double bonds.
Registry number: EC 5.2
(12 Dec 1998)
cis trans test <molecular biology> The complementation test with two or more interacting genes placed in cis and in trans relationships to each other. A double mutant genome is used in the cis test made from the two single mutant genomes used in the trans test by recombination.
If the wild type phenotype is restored by both cis and trans arrangements it is concluded that the two mutations are in different genes and hence that the phenotype is determined by more than one gene. If the trans test is negative and the cis positive this means that the two mutations are in the same gene. If both tests are negative then at least one of the mutations must be dominant. Thus the double test provides a means of fine mapping of genes.
A lab test which is used to determine whether two mutations of different genes which affect the same phenotype are on the same functional unit (indicating a cis configuration of the mutated genes) or on different functional units (indicating a trans configuration of the mutated genes). (A functional unit can be a chromosome.)
The test is done by mating an individual that has one of the mutations to an individual that has the other one, and observing whether their offspring have the mutant phenotype. If the offspring do not have the mutant phenotype, then the genes are known to be trans, because the offspring have normal copies of each mutant gene on the different functional units which are able to genetically complement each other. If the offspring do have the mutant phenotype, then the genes are known to be cis, because the offspring will always inherit at least one of the mutant genes on the one functional unit, resulting in the mutant phenotype.
(09 Oct 1997)
trans- 1. Prefix denoting across, through, beyond; opposite of cis-.
2. In genetics, denoting the location of two genes on opposite chromosomes of a homologous pair.
3. In organic chemistry, a form of geometric isomerism in which the atoms attached to two carbon atoms, joined by double bonds, are located on opposite sides of the molecule.
4. In biochemistry, a prefix to a group name in an enzyme name or a reaction denoting transfer of that group from one compound to another; e.g., transformylase (transfers a formyl group), transpeptidation.
Origin: L. Trans, through, across
(05 Mar 2000)
trans-1,2-dihydrobenzene-1,2-diol dehydrogenase <enzyme> Rat liver cytosol enzyme also catalyses 3alpha-hydroxysteroid dehydrogenase activity (EC 1.1.1.50); bphb isolated from pseudomonas
Registry number: EC 1.3.1.20
Synonym: acenaphthenol oxidase, dihydrodiol dehydrogenase, bphb gene product, biphenyl-2,3-dihydrodiol-2,3-dehydrogenase
(26 Jun 1999)
trans-2-hydroxybenzylidenepyruvate hydratase-aldolase <enzyme> Catalyses the hydration of cis-o-hydroxybenzylidenepyruvate with subsequent cleavage to form salicylaldehyde--important steps in the bacterial degradation of naphthalene to salicylate
Registry number: EC 4.2.1.-
Synonym: trans-o-hydroxybenzylidenepyruvate hydratase-aldolase, thbpa hydratase-aldolase
(26 Jun 1999)
trans-3-chloroacrylic acid dehalogenase <enzyme> Specific for conversion of trans-3-chloroacrylic acid to muconic saemialdehyde (3-oxopropionic acid); 34 amino-terminal amino acid sequence, with 3 questionable aas, given in first source
Registry number: EC 3.8.1.-
Synonym: trans-3caa dehalogenase
(26 Jun 1999)
trans-4-coumaroyl esterase <enzyme> From bacterial and fungal cultures; cleaves coumaric acid from plant cell wall polysaccharides; see also record for feruloyl-4-coumaroyl esterase
Registry number: EC 3.1.1.-
Synonym: trans-p-coumaroyl esterase, p-coumaroyl esterase, p-coumaric acid esterase
(26 Jun 1999)
trans-activation (genetics) Increased rate of gene expression directed by either viral or cellular proteins. These regulatory factors (diffusible gene products) act in trans -- that is, act on homologous or heterologous molecules of DNA. (cis-acting factors act only on homologous molecules.)
(12 Dec 1998)
trans-activators Diffusible gene products that act on homologous or heterologous molecules of viral or cellular DNA to regulate the expression of proteins.
(12 Dec 1998)
trans-bronchial biopsy <chest medicine, procedure> A biopsy that is performed through the wall of the bronchus (using the bronchoscope). This involves obtaining a small piece of lung tissue for microscopic analysis. This is a useful alternative to an open surgical biopsy, where an incision must be made.
(17 Mar 1998)
trans configuration 1. <chemistry> The configuration of an organic molecule containing a double bond between two carbon atoms, where the largest, most complex R groups attached to each carbon are on opposite sides.
Alternatively: The configuration of an organic molecule containing a ring, where the largest, most complex R groups attached to each carbon are on opposite sides.
These configurations are the opposite of cis configuration.
2. <genetics> A genetics term meaning that the changes in gene expression are due to something acting on the gene from a distance, or from an unrelated location, rather than on the same strand of DNA.
Two mutations in different genes coding for the same phenotype which are on opposite homologous chromosomes (as opposed to the cis configuration where both of the mutations are on the same homologue).
(17 Mar 1998)
trans Golgi network <cell biology> A complex of membranous tubules and vesicles, near the trans face of the Golgi, which is thought to be a major intersection for intracellular traffic of vesicles.
(18 Nov 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • trans
    °¡·ÎÁú·¯
  • fat
    ¶×¶×ÇÑ,±â¸§±â,¶×¶×ÀÌ
  • fat
    »ìÂð;Áö¹æÀÌ ¸¹Àº;ºñ¿ÁÇÑ;dzºÎÇÑ;À¯º¹ÇÑ;µÐ°¨ÇÑ;Áö¹æ;±â¸§±â;Á¦ÀÏÁÁÀº ºÎºÐ;»ìÂî(°ÔÇÏ)´Ù
  • fat cat
    Á¤Ä¡ ÀÚ±ÝÀ» ¸¹ÀÌ ¹ÙÄ¡´Â ºÎÀÚ;¼¼·Â°¡;À¯¸íÀÎ;µ· ¸¹Àº Ư±ÇÀÎ
  • fat city
    ´õÇÒ ¼ö ¾øÀÌ ÁÁÀº »óÅÂ(»óȲ,Àü¸Á)
  • fat farm
    =health spa
  • fat farm
    »ì»©´Â µµÀå
  • fat lamb
    ºñÀ° »õ³¢¾ç
  • fat lime
    ºÎ¼®È¸
  • green fat
    ¹Ù´Ù°ÅºÏÀÇ ±â¸§(Áø¹Ì)
  • puppy fat
    (À¯¾Æ±â,»çÃá±âÀÇ ÀϽÃÀû) ºñ¸¸
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á